— Know what they know.
Not Investment Advice

PBIO OTC

Pressure BioSciences, Inc.
1W: +0.0% 1M: -50.0% 3M: -71.4% YTD: -60.0% 1Y: -60.0% 3Y: -99.9% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Specialties · Tech Score Neutral · Power 46 · $8193 mcap · 41M float · 0.011% daily turnover · Short 97% of daily vol

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 1Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$—
Analysts0

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 18 Grade D
Profitability
3
Balance Sheet
9
Earnings Quality
30
Growth
48
Value
23
Momentum
50
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. PBIO scores highest in Momentum (50/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-50.34
Distress Zone
Piotroski F-Score
3/9
✗ ✗ ✓ ✓ ✓ ✗ ✗ ✗ ✗
Beneish M-Score
-17.65
Unlikely Manipulator
Ohlson O-Score
52.62
Bankruptcy prob: 100.0%
High Risk
Credit Rating
CCC
Score: 12.6/100
Trend: Stable
Earnings Quality
—
OCF/NI: 0.14x
Accruals: -629.5%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. PBIO scores -50.34, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. PBIO scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. PBIO's score of -17.65 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. PBIO's implied 100.0% bankruptcy probability signals significant financial distress. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. PBIO receives an estimated rating of CCC (score: 12.6/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-0.00x
PEG
-0.00x
P/S
0.00x
P/B
-0.00x
P/FCF
-0.55x
P/OCF
—
EV/EBITDA
-3.30x
EV/Revenue
23.87x
EV/EBIT
-3.23x
EV/FCF
-3.00x
Earnings Yield
-479.11%
FCF Yield
-182.16%
Shareholder Yield
19314.90%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. PBIO currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
2.837
EBT / EBIT
×
EBIT Margin
-7.387
EBIT / Rev
×
Asset Turnover
0.350
Rev / Assets
×
Equity Multiplier
-0.137
Assets / Equity
=
ROE
100.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. PBIO's ROE of 100.6% is driven by Asset Turnover (0.350), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$0.00
Median 1Y
$0.00
5th Pctile
$0.00
95th Pctile
$0.00
Ann. Volatility
651.7%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Richard T. Schumacher
President, CEO
$309,185 $— $320,535
Edmund Ting, Ph.D.
Senior Vice President of Engineering
$207,536 $— $215,163
Alexander Lazarev, Ph.D.
Vice President of Research and Development
$200,089 $— $202,272

CEO Pay Ratio

1:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $320,535
Avg Employee Cost (SGA/emp): $595,718
Employees: 15

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
15
0.0% YoY
Revenue / Employee
$131,851
Rev: $1,977,763
Profit / Employee
$-1,954,287
NI: $-29,314,298
SGA / Employee
$595,718
Avg labor cost proxy
R&D / Employee
$91,144
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Current
ROE 1.5% 1.3% 1.3% 1.4% 1.3% 1.1% 1.1% 1.0% 1.2% 1.0% 92.6% 85.4% 95.5% 84.8% 223.6% 244.5% 219.2% 195.7% 88.3% 1.0% 1.01%
ROA -4.9% -5.5% -6.3% -6.5% -5.8% -7.8% -8.6% -7.9% -6.5% -7.8% -7.8% -8.1% -7.7% -9.6% -2506.3% -2804.4% -2879.9% -4186.1% -6.8% -7.3% -7.33%
ROIC 1.5% 1.1% 91.5% 78.2% 72.2% 49.4% 40.1% 30.8% 44.7% 42.9% 38.8% 38.0% 33.7% 31.8% 45.9% 1.1% 62.5% 78.7% 55.6% 84.5% 84.51%
ROCE 69.9% 57.2% 56.7% 65.0% 62.2% 47.2% 36.2% 25.7% 31.6% 26.2% 22.4% 19.8% 20.8% 17.4% 21.6% 27.8% 20.3% 27.0% 22.7% 30.1% 30.12%
Gross Margin 43.0% -6.2% 31.0% 49.7% 53.7% 84.3% 59.6% 52.9% 50.2% 45.7% 34.5% 39.3% 12.4% -1.1% 51.6% 49.9% -55.6% -6.8% 33.2% 10.5% 10.49%
Operating Margin -2.1% -6.9% -5.5% -5.0% -1.5% -6.3% -1.9% -1.1% -2.4% -3.9% -2.3% -1.8% -9.5% -2.5% -4.9% -2.1% -4.1% -11.2% -4.3% -4.6% -4.57%
Net Margin -6.3% -13.2% -15.6% -17.0% -6.1% -25.5% -11.7% -7.8% -9.6% -12.3% -15.4% -9.9% -52.5% -5.6% -8614.7% -13.5% -15.2% -31.7% -23.1% -16.9% -16.87%
EBITDA Margin -2.5% -8.4% -9.2% -10.5% -2.0% -8.1% -3.3% -1.9% -3.0% -2.9% -3.3% -2.1% -16.6% -63.5% -3.8% -2.0% -3.1% -11.1% -7.5% -8.3% -8.28%
FCF Margin -3.2% -16.4% -18.9% -22.4% -21.4% -5.4% -4.2% -3.1% -3.6% -2.5% -2.3% -2.7% -2.8% -2.6% -2.1% -1.9% -1.5% -5.4% -7.6% -8.0% -7.97%
OCF Margin -3.2% -3.5% -3.9% -4.5% -3.9% -4.0% -3.1% -2.2% -2.7% -2.4% -2.3% -2.6% -2.7% -2.6% -2.1% -1.9% -1.5% -1.6% -2.9% -3.0% -2.96%
ROA 3Y Avg snapshot only -1276.60%
ROIC Economic snapshot only 84.51%
Cash ROA snapshot only -64.40%
NOPAT Margin snapshot only -4.55%
Pretax Margin snapshot only -20.95%
R&D / Revenue snapshot only 81.48%
SGA / Revenue snapshot only 4.88%
SBC / Revenue snapshot only 1.95%
Valuation
Metric Trend Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Current
P/E Ratio -0.47 -0.25 -0.43 -0.44 -0.35 -0.55 -0.55 -0.66 -0.92 -1.02 -0.93 -0.86 -0.61 -0.73 -0.00 -0.00 -0.00 -0.00 -0.22 -0.21 -0.000
P/S Ratio 2.43 1.63 3.75 5.14 4.11 7.24 6.69 6.68 10.21 10.29 10.19 10.05 10.15 9.89 9.95 6.61 1.86 3.76 4.40 4.37 0.004
P/B Ratio -0.56 -0.24 -0.43 -0.47 -0.38 -0.52 -0.50 -0.56 -0.95 -0.93 -0.79 -0.67 -0.49 -0.52 -0.61 -0.53 -0.15 -0.23 -0.18 -0.18 -0.000
P/FCF -0.76 -0.10 -0.20 -0.23 -0.19 -1.35 -1.59 -2.14 -2.81 -4.13 -4.34 -3.72 -3.67 -3.80 -4.75 -3.47 -1.21 -0.70 -0.58 -0.55 -0.549
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA -1.83 -1.61 -1.91 -1.73 -1.64 -2.44 -3.16 -4.72 -5.34 -6.35 -6.80 -7.07 -5.67 -6.96 -5.93 -4.92 -4.14 -3.53 -4.09 -3.30 -3.298
EV/Revenue 5.47 6.01 9.32 11.60 10.50 15.09 14.64 13.71 17.18 17.54 18.61 19.96 23.41 21.76 19.82 16.28 10.01 15.29 21.48 23.87 23.873
EV/EBIT -1.81 -1.58 -1.87 -1.70 -1.61 -2.40 -3.11 -4.60 -5.21 -6.16 -6.56 -6.80 -5.49 -6.67 -5.68 -4.72 -3.95 -3.44 -4.00 -3.23 -3.232
EV/FCF -1.70 -0.37 -0.49 -0.52 -0.49 -2.81 -3.48 -4.38 -4.73 -7.04 -7.94 -7.38 -8.46 -8.36 -9.47 -8.54 -6.52 -2.83 -2.81 -3.00 -2.996
Earnings Yield -2.1% -4.0% -2.3% -2.3% -2.8% -1.8% -1.8% -1.5% -1.1% -97.8% -1.1% -1.2% -1.6% -1.4% -323.0% -483.2% -1510.5% -861.3% -4.5% -4.8% -4.79%
FCF Yield -1.3% -10.1% -5.1% -4.4% -5.2% -74.1% -62.9% -46.8% -35.6% -24.2% -23.0% -26.9% -27.3% -26.3% -21.0% -28.9% -82.4% -1.4% -1.7% -1.8% -1.82%
Shareholder Yield snapshot only 193.15%
Leverage & Solvency
Metric Trend Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Current
Current Ratio 0.12 0.08 0.07 0.09 0.11 0.06 0.06 0.06 0.12 0.08 0.07 0.07 0.06 0.04 0.05 0.04 0.03 0.02 0.02 0.02 0.020
Quick Ratio 0.07 0.03 0.02 0.06 0.08 0.03 0.04 0.04 0.08 0.03 0.02 0.02 0.02 0.02 0.03 0.02 0.02 0.01 0.01 0.01 0.008
Debt/Equity -0.71 -0.66 -0.64 -0.60 -0.59 -0.57 -0.59 -0.59 -0.68 -0.66 -0.66 -0.66 -0.65 -0.63 -0.61 -0.77 -0.65 -0.70 -0.71 -0.78 -0.784
Net Debt/Equity — — — — — — — — — — — — — — — — — — — — —
Debt/Assets 2.85 4.38 4.76 3.43 2.92 4.17 4.90 5.71 4.07 5.17 5.65 6.26 6.79 10.22 8.98 11.58 11.56 21.80 3.88 4.24 4.244
Debt/EBITDA -1.04 -1.18 -1.15 -0.97 -1.01 -1.27 -1.72 -2.43 -2.28 -2.65 -3.10 -3.54 -3.25 -3.80 -2.99 -2.93 -3.37 -2.67 -3.25 -2.70 -2.695
Net Debt/EBITDA -1.02 -1.17 -1.14 -0.96 -1.00 -1.27 -1.72 -2.42 -2.17 -2.62 -3.08 -3.51 -3.21 -3.80 -2.95 -2.93 -3.37 -2.66 -3.25 -2.69 -2.694
Interest Coverage -1.38 -1.38 -1.28 -1.32 -1.28 -0.92 -0.63 -0.42 -0.43 -0.39 -0.44 -0.50 -0.65 -0.54 -0.59 -0.44 -0.32 -0.56 -0.50 -0.75 -0.751
Equity Multiplier -0.25 -0.15 -0.13 -0.17 -0.20 -0.14 -0.12 -0.10 -0.17 -0.13 -0.12 -0.11 -0.10 -0.06 -0.07 -0.07 -0.06 -0.03 -0.18 -0.18 -0.185
Cash Ratio snapshot only 0.000
Debt Service Coverage snapshot only -0.735
Cash to Debt snapshot only 0.000
FCF to Debt snapshot only -0.408
Defensive Interval snapshot only 8.5 days
Efficiency & Turnover
Metric Trend Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Current
Asset Turnover 0.95 0.86 0.72 0.55 0.50 0.59 0.71 0.78 0.59 0.78 0.72 0.70 0.47 0.71 0.78 0.88 1.02 1.29 0.34 0.35 0.350
Inventory Turnover 1.67 1.73 1.51 1.31 1.39 0.96 1.04 1.42 1.21 1.08 1.07 1.13 0.84 2.20 2.03 2.11 2.73 3.21 2.32 2.90 2.897
Receivables Turnover 5.64 5.14 5.51 4.90 3.60 6.77 4.88 4.97 4.26 14.00 4.83 3.83 4.08 7.68 5.82 7.92 9.17 8.86 5.91 8.02 8.024
Payables Turnover 2.22 1.62 1.58 1.35 1.30 0.73 0.80 1.09 1.42 1.45 1.50 1.77 1.78 3.46 2.87 2.75 3.03 1.63 0.91 0.93 0.932
DSO 65 71 66 74 101 54 75 73 86 26 76 95 90 48 63 46 40 41 62 45 45.5 days
DIO 218 211 242 278 263 379 350 257 301 337 340 322 436 166 180 173 134 114 157 126 126.0 days
DPO 165 225 231 271 282 497 455 334 257 252 244 206 205 106 127 133 121 225 399 392 391.7 days
Cash Conversion Cycle 118 57 77 82 82 -64 -31 -4 129 111 172 212 321 108 115 86 53 -70 -180 -220 -220.2 days
Fixed Asset Turnover snapshot only 2.287
Cash Velocity snapshot only 104.989
Capital Intensity snapshot only 4.597
Growth (YoY)
Metric Trend Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Current
Revenue -2.5% -26.4% -34.1% -41.8% -39.7% -32.6% -1.7% 43.3% 38.6% 64.0% 25.9% -3.0% -22.4% -13.6% 3.5% 10.6% 58.1% 14.4% -20.3% -25.3% -25.31%
Net Income -24.2% -20.2% -42.4% -53.5% -36.3% -37.3% -37.4% -22.4% -32.3% -25.9% -12.6% -12.5% -16.1% -15.5% -304.0% -301.4% -268.2% -274.1% 99.5% 99.5% 99.51%
EPS -1.4% 15.1% 7.3% 3.2% 25.7% 22.3% 25.2% 37.9% 36.8% 41.2% 43.5% 38.2% 21.2% 21.7% -185.7% -161.5% -137.0% -159.6% 99.8% 99.8% 99.81%
FCF -55.5% -4.2% -3.9% -3.5% -3.0% 78.0% 78.2% 80.0% 76.4% 23.8% 29.8% 16.1% 40.9% 9.9% 7.6% 22.0% 12.3% -1.4% -1.9% -2.1% -2.12%
EBITDA -49.2% -24.4% -29.1% -35.5% -29.1% -11.4% 6.8% 37.9% 30.3% 26.6% 25.5% 5.7% 0.4% 2.2% -26.5% -29.6% 7.4% -58.6% -25.4% -63.5% -63.52%
Op. Income -25.7% -29.7% -21.8% -9.3% -1.9% 21.0% 26.5% 37.5% 27.0% 8.7% 1.6% -24.3% -14.2% -17.0% -77.5% -71.4% -74.4% -1.0% -4.2% -12.9% -12.85%
OCF Growth snapshot only -16.54%
Asset Growth snapshot only 3.11%
Debt Growth snapshot only 50.44%
Shares Change snapshot only 1.64%
Dividend Growth snapshot only 23.93%
Growth (CAGR)
Metric Trend Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Current
Revenue 3Y 4.9% -2.9% -8.3% -14.0% -14.8% -18.3% -12.8% -8.0% -6.6% -6.6% -6.6% -6.8% -13.4% -1.5% 8.6% 15.4% 19.4% 17.5% 1.3% -7.1% -7.12%
Revenue 5Y 9.0% 5.7% 1.9% -3.0% -5.0% -7.5% -4.0% -1.0% -0.7% 0.3% -1.0% -2.4% -7.8% -5.0% -2.9% -3.5% -0.0% -4.3% -7.6% -7.7% -7.73%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y -9.3% -18.7% -25.1% -29.2% -26.2% -13.0% -1.6% 0.9% 1.0% -3.4% -6.5% -6.5% -15.4% — — — — -15.4% -48.7% — —
Gross Profit 5Y 2.3% -3.2% -8.0% -12.7% -12.8% -11.7% -6.2% -3.0% -1.9% -1.5% -5.3% -7.9% -15.3% — — — — -20.0% -35.6% — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y 8.4% 3.8% -0.2% 5.0% 16.1% 2.2% 3.2% -1.2% 13.9% 5.7% 4.8% 8.8% 5.6% 3.4% 6.6% -12.1% -18.5% -23.0% 41.2% 43.9% 43.94%
Assets 5Y 10.6% 0.8% 3.9% 12.6% 6.0% 5.0% 4.8% 4.8% 12.0% 11.7% 9.5% 6.3% 8.5% -1.4% -0.4% -6.9% -6.6% -15.2% 22.7% 25.2% 25.15%
Equity 3Y — — — — — — — — — — — — — — — — — — — — —
Book Value 3Y — — — — — — — — — — — — — — — — — — — — —
Dividend 3Y 141.8% 7.2% -16.4% -18.1% -22.4% -31.4% -28.1% -30.9% -34.4% -44.0% -60.2% -60.4% -60.3% -48.4% -36.2% -38.5% -36.3% — — -28.5% -28.48%
Growth Quality
Metric Trend Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Current
Revenue Stability 0.88 0.37 0.12 0.00 0.03 0.16 0.20 0.16 0.14 0.14 0.19 0.15 0.49 0.19 0.08 0.07 0.01 0.09 0.36 0.66 0.662
Earnings Stability 0.55 0.51 0.28 0.55 0.66 0.62 0.44 0.69 0.74 0.87 0.98 0.97 0.99 0.88 0.43 0.43 0.43 0.43 0.16 0.16 0.156
Margin Stability 0.83 0.81 0.78 0.78 0.80 0.76 0.72 0.73 0.77 0.81 0.77 0.76 0.76 0.13 0.33 0.37 0.20 0.04 0.12 0.00 0.000
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 1.00 0.50 0.50 0.50 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.90 0.92 0.83 0.50 0.85 0.85 0.85 0.91 0.87 0.90 0.95 0.95 0.94 0.94 0.50 0.50 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend — — — — — — — — — — — — — — — — — — — — —
Gross Margin Trend -0.11 -0.12 -0.12 -0.11 -0.06 0.11 0.19 0.21 0.19 0.10 0.01 -0.02 -0.10 -0.69 -0.56 -0.51 -0.58 0.01 -0.14 -0.27 -0.269
FCF Margin Trend -1.24 -14.34 -16.76 -20.06 -18.77 4.00 6.55 9.50 8.67 8.39 9.23 10.05 9.74 1.33 1.18 1.01 1.66 -2.85 -5.42 -5.66 -5.662
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Current
OCF/Net Income 0.63 0.54 0.45 0.38 0.34 0.31 0.26 0.22 0.25 0.24 0.21 0.23 0.16 0.19 0.00 0.00 0.00 0.00 0.15 0.14 0.141
FCF/OCF 1.00 4.69 4.85 5.01 5.48 1.34 1.35 1.40 1.33 1.03 1.03 1.03 1.04 1.00 1.01 1.00 1.00 3.35 2.62 2.69 2.691
FCF/Net Income snapshot only 0.380
CapEx/Revenue 1.3% 12.9% 15.0% 17.9% 17.5% 1.4% 1.1% 89.3% 90.0% 6.1% 6.2% 6.8% 9.7% 1.2% 1.1% 0.9% 0.3% 3.8% 4.7% 5.0% 5.01%
CapEx/Depreciation snapshot only 33.786
Accruals Ratio -1.83 -2.53 -3.45 -4.05 -3.83 -5.40 -6.44 -6.13 -4.90 -5.95 -6.17 -6.31 -6.46 -7.76 -2504.71 -2802.77 -2878.31 -4184.03 -5.77 -6.29 -6.295
Sloan Accruals snapshot only -4.075
Cash Flow Adequacy snapshot only -0.003
Dividends & Buybacks
Metric Trend Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Current
Dividend Yield 66.0% 190.1% 90.9% 79.0% 96.5% 70.6% 68.8% 56.3% 37.2% 28.5% 12.7% 13.7% 17.0% 26.4% 19.5% 29.2% 91.2% 0.0% 0.0% 193.1% 0.00%
Dividend/Share $180.93 $237.59 $200.03 $181.73 $146.61 $149.77 $144.46 $122.28 $92.96 $65.85 $25.63 $23.75 $22.33 $34.26 $24.39 $19.84 $17.79 $0.00 $0.00 $24.59 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Div. Increase Streak 0 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 — — 1 0
Chowder Number 5836950.28 1463.41 91.41 79.50 96.94 70.76 69.12 56.68 37.51 28.45 12.04 13.01 16.40 26.12 20.07 29.73 91.77 — — 195.42 195.421
Buyback Yield 47.3% 937.3% 481.7% 418.6% 510.9% 34.9% 212.8% 174.3% 115.0% 451.3% 418.2% 449.9% 561.7% 64.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 28.6% -190.1% -90.9% -79.0% -96.5% -83.1% -68.8% -56.3% -37.2% -28.6% -12.7% -13.7% -17.0% -175.9% -148.7% -222.3% -695.0% -1106.6% -1342.4% -1571.7% -1571.66%
Total Shareholder Return 94.7% 0.0% 0.0% 0.0% 0.0% 69.8% 0.0% 0.0% -4.8% -4.4% -4.7% -5.1% -0.1% -149.6% -129.1% -193.1% -603.8% -1106.6% -1342.4% -1378.5% -1378.51%
DuPont Factors
Metric Trend Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Current
Tax Burden (NI/EBT) 0.98 0.98 0.98 0.99 1.00 1.00 1.00 1.00 1.00 1.00 1.18 1.32 1.53 1.45 342.12 281.83 261.08 213.82 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.72 1.72 1.78 1.75 1.78 2.09 2.59 3.38 3.35 3.53 3.27 3.01 2.53 2.85 2.69 3.29 4.25 3.41 3.66 2.84 2.837
EBIT Margin -3.03 -3.80 -4.97 -6.81 -6.51 -6.28 -4.71 -2.98 -3.30 -2.85 -2.84 -2.93 -4.26 -3.26 -3.49 -3.45 -2.54 -4.44 -5.37 -7.39 -7.387
Asset Turnover 0.95 0.86 0.72 0.55 0.50 0.59 0.71 0.78 0.59 0.78 0.72 0.70 0.47 0.71 0.78 0.88 1.02 1.29 0.34 0.35 0.350
Equity Multiplier -0.31 -0.23 -0.21 -0.21 -0.22 -0.14 -0.13 -0.13 -0.18 -0.13 -0.12 -0.10 -0.12 -0.09 -0.09 -0.09 -0.08 -0.05 -0.13 -0.14 -0.137
Per Share
Metric Trend Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Current
EPS (Diluted TTM) $-5.77 $-4.94 $-5.12 $-5.27 $-4.29 $-3.84 $-3.83 $-3.27 $-2.71 $-2.26 $-2.16 $-2.02 $-2.13 $-1.77 $-403.80 $-328.59 $-294.54 $-284.24 $-0.78 $-0.61 $-0.61
Book Value/Share $-4.89 $-5.11 $-5.16 $-4.88 $-4.02 $-4.06 $-4.22 $-3.88 $-2.64 $-2.49 $-2.55 $-2.60 $-2.67 $-2.49 $-2.05 $-1.29 $-1.32 $-1.45 $-0.96 $-0.72 $-1.40
Tangible Book/Share $-5.19 $-5.35 $-5.37 $-5.06 $-4.17 $-4.18 $-4.32 $-3.96 $-2.70 $-2.53 $-2.59 $-2.64 $-2.71 $-2.51 $-2.07 $-1.30 $-1.33 $-1.45 $-1.09 $-0.83 $-0.83
Revenue/Share $1.13 $0.77 $0.59 $0.45 $0.37 $0.29 $0.31 $0.32 $0.24 $0.22 $0.20 $0.17 $0.13 $0.13 $0.13 $0.10 $0.10 $0.09 $0.04 $0.03 $0.08
FCF/Share $-3.62 $-12.59 $-11.12 $-10.01 $-7.91 $-1.57 $-1.32 $-1.02 $-0.89 $-0.56 $-0.46 $-0.47 $-0.36 $-0.34 $-0.26 $-0.20 $-0.16 $-0.47 $-0.30 $-0.23 $-0.14
OCF/Share $-3.61 $-2.68 $-2.29 $-2.00 $-1.44 $-1.17 $-0.98 $-0.73 $-0.67 $-0.55 $-0.45 $-0.46 $-0.34 $-0.34 $-0.26 $-0.20 $-0.16 $-0.14 $-0.12 $-0.09 $-0.14
Cash/Share $0.07 $0.01 $0.01 $0.01 $0.03 $0.00 $0.01 $0.01 $0.09 $0.01 $0.01 $0.01 $0.02 $0.00 $0.02 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
EBITDA/Share $-3.36 $-2.87 $-2.86 $-2.99 $-2.36 $-1.81 $-1.45 $-0.94 $-0.79 $-0.62 $-0.54 $-0.49 $-0.53 $-0.41 $-0.42 $-0.34 $-0.25 $-0.38 $-0.21 $-0.21 $-0.21
Debt/Share $3.49 $3.37 $3.28 $2.90 $2.39 $2.30 $2.50 $2.29 $1.79 $1.64 $1.68 $1.73 $1.73 $1.56 $1.25 $1.00 $0.85 $1.02 $0.68 $0.57 $0.57
Net Debt/Share $3.42 $3.36 $3.27 $2.89 $2.36 $2.30 $2.49 $2.28 $1.71 $1.63 $1.67 $1.72 $1.71 $1.56 $1.24 $1.00 $0.85 $1.01 $0.68 $0.57 $0.57
Academic Models
Metric Trend Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — -50.336
Altman Z-Prime snapshot only -139.595
Piotroski F-Score 1 1 1 2 2 3 2 3 3 3 3 3 1 2 3 3 2 3 3 3 3
Beneish M-Score -10.45 -20.35 -22.45 -19.17 -17.22 -25.82 -26.82 -31.54 -24.84 -26.96 -29.55 -29.61 -34.73 -46.12 -13511.80 -17856.46 -18672.89 -28525.11 -18.89 -17.65 -17.648
Ohlson O-Score snapshot only 52.621
Net-Net WC snapshot only $-0.84
Credit
Metric Trend Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Current
Credit Rating snapshot only CCC
Credit Score 12.56 12.89 12.95 12.87 12.61 12.61 12.58 12.57 12.85 13.01 13.11 12.82 13.27 13.00 13.04 12.77 12.61 12.58 12.62 12.60 12.596
Credit Grade snapshot only 17
Credit Trend snapshot only -0.179
Implied Spread (bps) snapshot only 1200.000
Industry Credit Rank snapshot only 0
Sector Credit Rank snapshot only 1

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms